Will Zevra Therapeutics announce a new clinical trial for Miplyffa by Mar 31, 2025? | Binary | | | 3 months ago | |
What will be Zevra Therapeutics' revenue growth rate in 2024? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics' stock price increase by 20% or more by end of 2024? | Binary | | | 3 months ago | |
Will Miplyffa's sales reach $50 million by end of Q1 2025? | Binary | | | 3 months ago | |
What will be the revenue generated by Miplyffa for Zevra Therapeutics in the fiscal year 2024? | Categorical | | | 3 months ago | |
What will be the performance of Zevra Therapeutics' stock price by end of 2024? | Categorical | | | 3 months ago | |
How many prescriptions for Miplyffa will be filled by end of Q1 2025? | Categorical | | | 3 months ago | |
Will Zevra Therapeutics receive the $150M Priority Review Voucher by end of 2024? | Binary | | | 3 months ago | |
Will the FDA approve another treatment for Niemann-Pick disease, type C by Dec 31, 2024? | Binary | | | 3 months ago | |
How many patients will be treated with Miplyffa by Dec 31, 2024? | Categorical | | | 3 months ago | |
What will be the market share of Miplyffa in the Niemann-Pick disease, type C treatment market by Dec 31, 2024? | Categorical | | | 3 months ago | |
